References
- Ullah K, O’Reilly A, Power DG, et al. A case series of patients on chemotherapy with dyspnoea and pulmonary infiltrates. BMJ Case Rep. 2013 Published 2013 Jun 5;2013:bcr2013009105.
- Barlési F, Villani P, Doddoli C, et al. Gemcitabine-induced severe pulmonary toxicity. Fundam Clin Pharmacol. 2004;18:85–91.
- Rübe CE, Wilfert F, Uthe D, et al. Increased expression of pro-inflammatory cytokines as a cause of lung toxicity after combined treatment with gemcitabine and thoracic irradiation. Radiother Oncol. 2004;72(2):231–241.
- Haupt HM, Hutchinson GM, Moore GW. Ara-C: non-cardiogenic pulmonary edema complicating cytosine arabinoside therapy in acute leukemia. Am J Med. 1981;70:256–261.
- Pavlakis N, Levi JA, Wheeler HR, Begbie SD, Bell DR: Novel pulmonary and neurological (GNS) toxicities with Gemcitabine. Proc ASCO 15: 181, 1996.
- Tham R, Peters WG, de Bruine FJ, et al. Pulmonary complications of cytosine arabinoside therapy: radiological findings. Am J Roentgenol. 1987;70:251–261.
- Comito F, Grassi E, Poerio A, Freier E, Calculli L, Zompatori M, Ricci C, Casadei R, Di Marco M. Organizing pneumonia after pancreatic cancer treatment with nab-paclitaxel and gemcitabine: a case report. BJR| case reports. 2018 Jun;4(2):20170086.
- Fenocchio E, Depetris I, Campanella D, et al. Successful treatment of gemcitabine-induced acute interstitial pneumonia with imatinib mesylate: a case report. BMC Cancer. 2016;16(1). DOI:10.1186/s12885-016-2833-9